MTOR and non-small cell lung carcinoma: We set out to use Spa-R to quantify NSCLC histopathology-selective oncogenic signalling activities, with primary focus on the PI3K/AKT, MAPK, and mTOR pathways, as well as the p38MAPK stress-sensing pathway (Fig. 2b).